Data / Research funding / Primary Immunodeficiencies
Primary Immunodeficiencies: 223 NIH awards ($309M) to 85 organizations
223 NIH awards ($309M) in the NIH spending category Primary Immunodeficiencies, to 85 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
223 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $32,128,916 | February 1, 2025 | January 31, 2026 | MILLIN, CHRISTINA | reporter.nih.gov |
| USIDNET: A resource for clinical immunologists | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,578,391 | August 24, 2022 | July 31, 2027 | SULLIVAN, KATHLEEN E | reporter.nih.gov |
| Multi-racial genetic analysis of hidradenitis suppurativa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $4,095,633 | July 16, 2021 | June 30, 2026 | LIAO, WILSON | reporter.nih.gov |
| Collaborative multi-site project to speed the identification and management of rare genetic immune diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,948,415 | February 25, 2021 | January 31, 2027 | BUTTE, MANISH J | reporter.nih.gov |
| Inborn errors of immunity in patients with life-threatening COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,707,765 | July 12, 2021 | June 30, 2026 | CASANOVA, JEAN-LAURENT | reporter.nih.gov |
| Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,580,422 | September 1, 2025 | August 31, 2029 | DVORAK, CHRISTOPHER CRAIG | reporter.nih.gov |
| Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,369,470 | July 7, 2016 | December 31, 2029 | WILLIAMS, DAVID A | reporter.nih.gov |
| Second-Generation Novel Liver Stage Active Antimalarials | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,320,110 | April 1, 2021 | March 31, 2027 | KELLY, JANE X | reporter.nih.gov |
| Developing second generation SCID pig models: filling the gaps to improve translation of therapeutics in regenerative medicine | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $3,219,338 | February 15, 2020 | July 31, 2029 | TUGGLE, CHRISTOPHER | reporter.nih.gov |
| GENETIC, IMMUNOLOGIC AND MECHANISTIC BASIS OF HUMAN NK CELL DEFICIENCY | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,093,388 | January 19, 2016 | August 31, 2026 | ORANGE, JORDAN SCOTT | reporter.nih.gov |
| Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,070,980 | February 1, 2022 | January 31, 2027 | MORROW, BERNICE E | reporter.nih.gov |
| The molecular and cellular mechanisms of the STAT3 mutation-mediated pulmonary disorder in Autosomal Dominant Hyper IgE Syndrome (AD-HIES) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,990,146 | March 5, 2022 | February 28, 2026 | BOUCHER, RICHARD CHARLES | reporter.nih.gov |
| Identification of metabolic alterations during cortical development in a human cellular model for 22q11.2 deletion syndrome | NIH | National Institute of Mental Health | 2022 to 2025 | $2,912,854 | January 18, 2022 | October 31, 2026 | PASCA, ANCA MIRABELA | reporter.nih.gov |
| Mechanisms of mucosal autoinflammation elucidated by a novel monogenic transcription factor defect | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,902,111 | April 15, 2021 | March 31, 2026 | LUCAS, CARRIE L. | reporter.nih.gov |
| Mechanisms of STING-associated autoinflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,866,706 | March 1, 2019 | January 31, 2029 | MINER, JONATHAN J | reporter.nih.gov |
| Pathobiology of VPS45 severe congenital neutropenia | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,830,535 | February 7, 2020 | January 31, 2026 | NEWBURGER, PETER E | reporter.nih.gov |
| WAVE Regulatory Complex in Primary Immunodeficiency Disease and autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,801,318 | February 10, 2021 | January 31, 2026 | IRITANI, BRIAN M | reporter.nih.gov |
| Strawberry notch homologues in T cell homeostasis and function | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,783,309 | January 21, 2021 | December 31, 2026 | ZHONG, XIAOPING | reporter.nih.gov |
| Restoring Immune Balance in Hiddradenitis Suppurativa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,776,428 | May 1, 2020 | April 30, 2026 | ROSENBLUM, MICHAEL DAVID | reporter.nih.gov |
| Phage/Salmonella interactions during oxidative stress | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,727,148 | September 4, 2025 | August 31, 2029 | VAZQUEZ-TORRES, ANDRES | reporter.nih.gov |
| Regulation of 22q11 Genes in Embryonic and Adult Forebrain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,688,826 | April 1, 2003 | June 30, 2027 | LAMANTIA, ANTHONY S | reporter.nih.gov |
| Unraveling the molecular mechanisms of impaired central tolerance in COPA syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,664,560 | March 1, 2022 | February 28, 2027 | SHUM, ANTHONY | reporter.nih.gov |
| Lead optimization and target identification of drugs targeting hypnozoites | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,647,674 | August 7, 2020 | July 31, 2025 | KYLE, DENNIS E | reporter.nih.gov |
| Cell fate choices by Tbx1 in forming the mammalian heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,603,457 | August 20, 2020 | April 30, 2029 | MORROW, BERNICE E | reporter.nih.gov |
| The Genetics of Personalized Functional MRI Networks | NIH | National Institute of Mental Health | 2023 to 2025 | $2,562,033 | June 16, 2023 | March 31, 2026 | ALEXANDER-BLOCH, AARON FELIX | reporter.nih.gov |
| Inborn errors of immunity in children with herpes simplex encephalitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,560,389 | April 6, 2010 | March 31, 2026 | CASANOVA, JEAN-LAURENT | reporter.nih.gov |
| Genome-Wide Dissection of Mendelian Susceptibility to Mycobacterial Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,542,500 | May 1, 2011 | April 30, 2027 | CASANOVA, JEAN-LAURENT | reporter.nih.gov |
| Novel Multiple-Stage Active Antimalarials | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,520,964 | June 14, 2019 | August 31, 2030 | KANCHARLA, PAPIREDDY | reporter.nih.gov |
| New York Regional Inborn Errors of Immunity Resource Initiative League (NY-ROYAL) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,501,144 | September 1, 2023 | August 31, 2028 | MILNER, JOSHUA D. | reporter.nih.gov |
| Mechanisms of STING-driven autoinflammation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,494,975 | May 15, 2023 | April 30, 2027 | FITZGERALD, KATHERINE A. | reporter.nih.gov |
| Genome-wide search for inborn errors of IL-17 immunity underlying chronic mucocutaneous candidiasis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,457,750 | November 14, 2016 | February 28, 2027 | CASANOVA, JEAN-LAURENT | reporter.nih.gov |
| Adenylate Kinase 2 Deficiency and the Failure of Myelopoiesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,449,815 | April 1, 2022 | March 31, 2027 | WEINACHT, KATJA GABRIELE | reporter.nih.gov |
| Hermansky-Pudlak syndrome and melanosome formation | NIH | National Eye Institute | 2022 to 2025 | $2,448,434 | May 1, 2004 | June 30, 2027 | MARKS, MICHAEL S | reporter.nih.gov |
| Intracellular nucleic acid detection in autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,440,748 | May 15, 2010 | April 30, 2025 | STETSON, DANIEL B | reporter.nih.gov |
| Molecular Genetics of the Telomere Biology Disorders | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,421,352 | May 15, 2016 | June 30, 2026 | BERTUCH, ALISON A | reporter.nih.gov |
| Washington University in St. Louis UDN Diagnostic Center of Excellence | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,411,983 | September 21, 2018 | July 31, 2028 | DICKSON, PATRICIA I | reporter.nih.gov |
| Underdiagnosis of primary immunodeficiency disorders among racial and ethnic minorities: Recognize and Educate | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2024 | $2,386,620 | September 19, 2022 | May 31, 2027 | ONG, MEI-SING | reporter.nih.gov |
| Regulation of Ribosome Biogenesis in Hematopoietic Stem Cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,385,337 | September 18, 2020 | August 31, 2025 | TONG, WEI | reporter.nih.gov |
| Hematopoietic Regulation via GATA Switches | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,385,213 | February 1, 2006 | November 30, 2029 | BRESNICK, EMERY H. | reporter.nih.gov |
| Omics, mice and men: Development of precision transfusion medicine | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,341,220 | September 18, 2009 | July 31, 2028 | GLADWIN, MARK T | reporter.nih.gov |
| Molecular Dissection of the 22q11.2 Deletion Syndrome | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,272,016 | August 15, 2018 | August 31, 2025 | EMANUEL, BEVERLY S | reporter.nih.gov |
| Neurodevelopmental defects of the thalamocortical pathway as a convergent feature of psychiatric disorders | NIH | National Institute of Mental Health | 2023 to 2025 | $2,271,274 | May 1, 2023 | January 31, 2028 | NOWAKOWSKI, TOMASZ | reporter.nih.gov |
| Survival Function of the Fadd-Caspase-8-Flip Complex - MERIT Extension | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,268,750 | May 1, 2022 | April 30, 2027 | GREEN, DOUGLAS R. | reporter.nih.gov |
| Tafazzin and metabolic reprogramming during cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,259,577 | September 1, 2021 | August 31, 2025 | CONWAY, SIMON JAMES | reporter.nih.gov |
| Regulation of SAMHD1 antiviral activity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,242,957 | September 20, 2016 | June 30, 2025 | DIAZ-GRIFFERO, FELIPE | reporter.nih.gov |
| Mechanisms driving extrafollicular polyreactive B cell lineages in partial RAG deficiency | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,232,177 | September 22, 2021 | August 31, 2027 | WALTER, JOLAN ESZTER | reporter.nih.gov |
| Molecular and cellular mechanisms in food anaphylaxis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,192,068 | June 1, 2020 | May 31, 2025 | GEHA, RAIF SALIM | reporter.nih.gov |
| Molecular Pathogenesis of Fanconi Anemia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,183,099 | August 1, 1994 | December 31, 2027 | D'ANDREA, ALAN D. | reporter.nih.gov |
| Neurodevelopment and Psychosis in the 22q11.2 Copy Number Variants | NIH | National Institute of Mental Health | 2023 to 2025 | $2,163,535 | December 14, 2009 | April 30, 2028 | BEARDEN, CARRIE E | reporter.nih.gov |
| Clinical and mechanistic studies defining optimal preparative approaches to infants with IL2RG/JAK3/RAG1/RAG2 SCID: a randomized trial of busulfan dosage | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,149,845 | August 13, 2024 | May 31, 2029 | AULETTA, JEFFERY J | reporter.nih.gov |
| Site-Specific Recombination in Human Health & Disease | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,145,000 | June 1, 2016 | May 31, 2027 | LIEBER, MICHAEL R | reporter.nih.gov |
| Mechanism and regulation of DNA interstrand cross-link repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,138,165 | February 1, 2010 | July 31, 2028 | WALTER, JOHANNES | reporter.nih.gov |
| Curation of genetic defects causing combined immunodeficiency and infections in children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,115,359 | July 1, 2021 | June 30, 2028 | CHINN, IVAN KINGYUE | reporter.nih.gov |
| Epigenetic dysregulation of muscle differentiation in Kabuki syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,111,652 | February 2, 2022 | December 31, 2026 | GUSSONI, EMANUELA | reporter.nih.gov |
| Mechanistic elucidation of pathogenic CBM complex mutations associated with atopic disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,100,471 | July 5, 2023 | June 30, 2028 | SNOW, ANDREW L | reporter.nih.gov |
| Innate immune defenses against a cytosolic capsule | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,085,271 | December 1, 2018 | April 30, 2030 | MIAO, EDWARD A | reporter.nih.gov |
| Biochemistry and molecular physiology of the mitochondrial calcium uniporter | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,072,213 | September 1, 2018 | June 30, 2029 | GRABAREK, ZENON | reporter.nih.gov |
| Olfactory and facial markers of developmental risk for psychosis in 22q11 deletion syndrome | NIH | National Institute of Mental Health | 2021 to 2024 | $2,059,648 | September 24, 2019 | January 31, 2025 | ROALF, DAVID R | reporter.nih.gov |
| Thymic medullary epithelial cell turnover and control of immune tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,051,250 | December 1, 2011 | June 30, 2027 | ANDERSON, MARK S | reporter.nih.gov |
| Dissecting the role of acetaldehyde in oral carcinogenesis | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,048,776 | September 20, 2022 | August 31, 2027 | BALBO, SILVIA | reporter.nih.gov |
| Skin probiotics to treat Netherton Syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $2,033,762 | September 15, 2022 | August 30, 2026 | ZARGAR, AMIN | reporter.nih.gov |
| Neutrophil Extracellular Traps and Host Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,025,000 | March 4, 2021 | February 28, 2027 | SHARMA, JYOTIKA | reporter.nih.gov |
| Structural Mechanisms of DNA Damage Sensing and Activation of the ATR, Fanconi Anemia, and ATM Checkpoints | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $2,017,785 | August 1, 2023 | April 30, 2027 | PAVLETICH, NIKOLA P | reporter.nih.gov |
| Molecular mechanisms and treatment of cardiomyopathy in Barth Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,974,688 | April 1, 2021 | March 31, 2026 | FANG, XI | reporter.nih.gov |
| The role of SERPINB1 in T cell function and its contribution to human diseases | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,957,554 | July 5, 2023 | June 30, 2028 | MARTINEZ BARRICARTE, RUBEN | reporter.nih.gov |
| Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure Renewal | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,842,526 | March 1, 2014 | June 30, 2028 | CARCILLO, JOSEPH A | reporter.nih.gov |
| The role of inflammation in driving leukemogenesis in germline predisposition syndromes | NIH | National Cancer Institute | 2023 to 2025 | $1,807,914 | May 1, 2022 | April 30, 2026 | GODLEY, LUCY ANN | reporter.nih.gov |
| Genome Stability in Glia & Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,806,350 | July 1, 2022 | June 30, 2027 | MCKINNON, PETER J | reporter.nih.gov |
| Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,769,742 | March 20, 2020 | February 28, 2026 | ZHOU, YANG | reporter.nih.gov |
| In vivo hematopoietic stem cell genetic modification by viral particles | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,764,905 | September 9, 2024 | May 31, 2028 | BAUER, DANIEL EVAN | reporter.nih.gov |
| Kindlin-3 signaling in platelets | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,742,425 | February 10, 2022 | January 31, 2026 | MA, YAN-QING | reporter.nih.gov |
| Common Regulatory Pathways for the Genesis of Lysosome-Related Organelles and Dynamics of Microtubules during Development | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,738,337 | September 30, 2020 | August 31, 2025 | GLOVER, DAVID M | reporter.nih.gov |
| Coding and Noncoding RNA Contributions to 22q11.2 Deletion Syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,737,187 | July 1, 2015 | June 30, 2026 | VAN OERS, NICOLAI STANISLAS CYRILLE | reporter.nih.gov |
| Safety and Efficacy of Itacitinib in treatment of JAK/STAT pathway disorders with activating mutations | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $1,700,517 | September 1, 2021 | July 31, 2028 | FORBES, LISA | reporter.nih.gov |
| Aire, a zinc-finger protein that controls autoimmunity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,678,050 | March 1, 2002 | April 30, 2027 | MATHIS, DIANE J | reporter.nih.gov |
| Defining WASp-dependent pathways in replication stress | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,636,788 | August 7, 2023 | July 31, 2026 | VYAS, YATIN M | reporter.nih.gov |
| Investigation of Self-Nucleic Acids as a Trigger for Neuroinflammation | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,626,825 | June 1, 2022 | May 31, 2027 | CHUNG, HACHUNG | reporter.nih.gov |
| 1/2: Neurodevelopmental Trajectories in 22q11.2 Deletion Syndrome in Adolescence and Young Adulthood | NIH | National Institute of Mental Health | 2024 to 2025 | $1,580,588 | February 13, 2024 | December 31, 2028 | GUR, RAQUEL E | reporter.nih.gov |
| Dissecting the Molecular Role of TBX1 in the Context of Human Pharyngeal Endoderm Development | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,574,000 | May 1, 2022 | October 31, 2025 | SEBASTIANO, VITTORIO | reporter.nih.gov |
| Molecular and cellular basis of epidermodysplasia verruciformis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,557,826 | February 10, 2020 | January 31, 2026 | CASANOVA, JEAN-LAURENT | reporter.nih.gov |
| Identification of Specific Immune Responses in African American Female Patients with Hidradenitis Suppurativa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,553,425 | September 18, 2024 | August 31, 2029 | MI, QING-SHENG | reporter.nih.gov |
| Characterizing the natural history of sphingosine phosphate lyase insufficiency syndrome (SPLIS): a fundamental step in the development of a targeted cure for this novel atypical sphingolipidosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,535,635 | September 10, 2024 | June 30, 2029 | SABA, JULIE D | reporter.nih.gov |
| Mechanism and Regulation of eIF6 in Translation | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,493,845 | July 7, 2022 | April 30, 2027 | ORIGANTI, SOFIA | reporter.nih.gov |
| Nqo2 in Primaquine-Induced Hemolysis of G6PD-deficient RBCs | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,463,166 | May 15, 2024 | April 30, 2028 | GOLDFARB, ADAM N. | reporter.nih.gov |
| Enhancer activation mechanisms in cranial neural crest osteoblast differentiation | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $1,444,084 | September 1, 2021 | July 31, 2026 | SHPARGEL, KARL BRYAN | reporter.nih.gov |
| Selective inhibitors of MLCL/CytC Peroxidase in Barth Syndrome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,430,854 | July 1, 2024 | June 30, 2028 | KAGAN, VALERIAN E | reporter.nih.gov |
| Modeling and treating T cell immunodeficiency in CHARGE syndrome by ESC- and iPSC-derived thymic epithelial cells | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,352,273 | February 1, 2023 | January 31, 2028 | LAI, LAIJUN | reporter.nih.gov |
| Investigating and targeting the translational landscape of DBA | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,351,443 | August 1, 2024 | May 31, 2029 | BARNA, MARIA | reporter.nih.gov |
| Development, Optimization and Preclinical Modeling of Hematopoietic Stem Cell Gene Editing for the Treatment of RAG1 Immunodeficiency | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,327,500 | June 8, 2021 | May 31, 2026 | GENOVESE, PIETRO | reporter.nih.gov |
| Ion channels regulating plasma cell differentiation and humoral immunity | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,317,151 | December 13, 2023 | October 31, 2028 | FESKE, STEFAN | reporter.nih.gov |
| Linking mitochondrial and synaptic weakness to schizophrenia | NIH | National Institute of Mental Health | 2024 to 2025 | $1,300,778 | July 19, 2024 | January 31, 2027 | ANDERSON, STEWART A | reporter.nih.gov |
| Hypoxia's role in regulating stressed hematopoietic stem cells | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,300,278 | March 1, 2024 | December 31, 2027 | KAPUR, REUBEN | reporter.nih.gov |
| Development of real-world motor outcome measures in ataxia-telangiectasia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,275,758 | December 15, 2023 | November 30, 2028 | GUPTA, ANOOPUM SATYAWAN | reporter.nih.gov |
| Mechanisms of R loop-mediated genome instability in Wiskott-Aldrich syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $1,273,819 | February 7, 2020 | January 31, 2026 | VYAS, YATIN M | reporter.nih.gov |
| Redox Regulation of Gingival Inflammation | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2024 | $1,257,475 | December 9, 2019 | November 30, 2025 | BAGAITKAR, JUHI | reporter.nih.gov |
| Mechanistic dissection of 22q11.2DS in zebrafish | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,242,466 | March 1, 2024 | February 29, 2028 | BURNS, CAROLINE E | reporter.nih.gov |
| Defining cerebellar pathophysiology in Ataxia Telangiectasia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,223,426 | January 15, 2024 | December 31, 2028 | MATHEWS, PAUL JAMES | reporter.nih.gov |
| Mechanisms of Plk1 at the mitotic centromere | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,222,450 | April 1, 2021 | March 31, 2025 | WEAVER, BETH A | reporter.nih.gov |
| Mechanisms of genetic variants in TH2 autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,212,458 | July 5, 2024 | May 31, 2029 | GORONZY, JORG J | reporter.nih.gov |
| Combined Photoacoustic and Ultrasound Imaging for Enabling Quantitative Evaluation of Hidradenitis Suppurativa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,207,758 | March 15, 2024 | January 31, 2028 | AVANAKI, KAMRAN | reporter.nih.gov |
| Defining the mechanistic basis of ATM’s impact on VDJ recombination | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,162,500 | May 20, 2019 | April 30, 2026 | MEEK, KATHERYN D | reporter.nih.gov |
| LUBAC-dependent regulation of cell death | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,153,501 | September 1, 2021 | May 31, 2026 | LOPEZ-MOSQUEDA, JAIME | reporter.nih.gov |
| Molecular and cellular mechanisms in cardiac outflow tract formation and defects | NIH | National Heart, Lung, and Blood Institute | 2024 | $1,107,221 | September 1, 2021 | August 31, 2025 | ZHOU, BIN | reporter.nih.gov |
| Mitochondrial influences on blood brain barrier function and neuropsychiatric illness | NIH | National Institute of Mental Health | 2024 to 2025 | $1,100,197 | April 1, 2024 | October 31, 2027 | ALVAREZ, JORGE IVAN | reporter.nih.gov |
| Efficacy and mechanisms of anti-IFN drugs in AGS treatment | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,079,864 | February 1, 2024 | January 31, 2029 | BILLIAR, TIMOTHY R | reporter.nih.gov |
| Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes Mellitus | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,042,875 | June 1, 2023 | May 31, 2026 | POLLIN, TONI I. | reporter.nih.gov |
| Leveraging a novel human inborn error of immunity to understand B cell development and function | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,028,494 | July 2, 2024 | May 31, 2029 | MARKLE, JANET G | reporter.nih.gov |
| The adaptor protein Crk in immune responses | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,006,108 | February 13, 2018 | January 31, 2029 | LIU, DONGFANG | reporter.nih.gov |
| Analyzing Genes for Autoimmune Thyroiditis and Diabetes: Translation to Therapy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $981,321 | March 1, 2005 | November 30, 2029 | TOMER, YARON | reporter.nih.gov |
| Novel sources of endogenous DNA damage in hematopoietic stem progenitor cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $942,040 | September 20, 2021 | February 28, 2025 | JUNG, MOONJUNG | reporter.nih.gov |
| Molecular Basis of Coats Plus Disease | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $910,185 | January 1, 2023 | December 31, 2026 | CHAI, WEIHANG | reporter.nih.gov |
| Mechanisms of Chromosome Shattering from Defective DNA Replication | NIH | National Cancer Institute | 2024 to 2025 | $903,640 | April 1, 2024 | March 31, 2029 | LY, PETER | reporter.nih.gov |
| Human ISG15 and USP18 Deficiencies Underlying Type I Interferonopathies | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $897,474 | April 16, 2024 | May 31, 2027 | BOGUNOVIC, DUSAN | reporter.nih.gov |
| 2/2 - Neurodevelopmental Trajectories in 22q11.2 Deletion Syndrome in Adolescence and Young Adulthood | NIH | National Institute of Mental Health | 2024 to 2025 | $895,979 | February 13, 2024 | December 31, 2028 | MCDONALD-MCGINN, DONNA MARIE | reporter.nih.gov |
| The role of cortisol synthesis in pathogenesis of Hidradenitis suppurativa tunnels | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $885,777 | September 2, 2024 | July 31, 2029 | TOMIC-CANIC, MARJANA | reporter.nih.gov |
| Determining the Genetic Basis of Hidradenitis Suppurativa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $855,689 | August 22, 2024 | July 31, 2029 | SAYED, CHRISTOPHER J | reporter.nih.gov |
| Role of the brain-immune axis in neuropsychiatric disease | NIH | National Institute of Mental Health | 2024 to 2025 | $831,339 | November 15, 2023 | October 31, 2028 | ALVAREZ, JORGE IVAN | reporter.nih.gov |
| Use of Tiered Genetic Sequencing and Specialty Referral for Identifying and Managing Rare Genetic Causes of Chronic Suppurative Respiratory Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $826,852 | January 15, 2024 | December 31, 2027 | OLIVIER, KENNETH N. | reporter.nih.gov |
| Genetic determinates of SPI1 expression and activity in human germinal center B cells | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $820,623 | February 1, 2025 | January 31, 2030 | ROMBERG, NEIL DAVID | reporter.nih.gov |
| CRISPR Editing of Primary Human Cells to Model and Correct Primary Immunodeficiency Mutations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $794,940 | July 1, 2020 | June 30, 2025 | NGUYEN, DAVID-HUY NHU | reporter.nih.gov |
| Genetic, Immunologic and Mechanistic Basis of Human NK Cell Deficiency | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $789,847 | January 19, 2016 | August 31, 2026 | ORANGE, JORDAN SCOTT | reporter.nih.gov |
| Regulation of coagulation and thrombosis by C1 inhibitor | NIH | National Heart, Lung, and Blood Institute | 2025 | $788,721 | August 1, 2025 | July 31, 2029 | GROVER, STEVEN P. | reporter.nih.gov |
| The molecular circuits controlling human T follicular regulatory cell development | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $781,685 | December 9, 2024 | November 30, 2029 | ROMBERG, NEIL DAVID | reporter.nih.gov |
| Differential regulation of cell cycle entry and apoptosis in cytolytic lymphocytes informed by primary immunodeficiency | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $764,591 | August 1, 2025 | July 31, 2030 | MACE, EMILY MARGARET | reporter.nih.gov |
| Ribosomal RNA modification in nucleoli and disease | NIH | National Heart, Lung, and Blood Institute | 2024 | $755,156 | September 13, 2024 | August 31, 2025 | MEIER, U THOMAS | reporter.nih.gov |
| Pain in Hidradenitis Suppurativa: Phenotypes and Stakeholder Perspectives | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $743,903 | July 8, 2022 | June 30, 2027 | ORENSTEIN, LAUREN ANNE VIGIL | reporter.nih.gov |
| Cooperative dysfunction of thalamocortical and cerebellar inputs to the auditory cortex in 22q11.2 deletion syndrome model of schizophrenia. | NIH | National Institute of Mental Health | 2025 | $731,035 | June 1, 2025 | March 31, 2030 | ZAKHARENKO, STANISLAV S | reporter.nih.gov |
| Mechanisms of control of allergic skin inflammation by T regulatory cells | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $716,281 | July 24, 2025 | June 30, 2030 | GEHA, RAIF SALIM | reporter.nih.gov |
| Understanding Cardiac Mitochondrial Quality Control Through the Lens of Barth Syndrome | NIH | National Heart, Lung, and Blood Institute | 2025 | $704,913 | May 1, 2025 | February 28, 2029 | VERNON, HILARY | reporter.nih.gov |
| Genetic Dissection of Stress Responses in Shwachman-Diamond Syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $701,158 | June 22, 2023 | May 31, 2026 | COREY, SETH JOEL | reporter.nih.gov |
| Establishing the contributions of monogenic etiologies to hidradenitis suppurativa pathogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $700,744 | June 1, 2024 | May 31, 2029 | PETUKHOVA, LYNN | reporter.nih.gov |
| Regulation of coagulation and thrombosis by C1 inhibitor | NIH | National Heart, Lung, and Blood Institute | 2024 | $685,884 | September 1, 2024 | July 31, 2029 | GROVER, STEVEN P. | reporter.nih.gov |
| The role of Rpl5 haploinsufficiency in hematopoietic stem/progenitor cell function in Diamond Blackfan anemia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $679,740 | March 1, 2022 | February 28, 2027 | SINGH, SHARON A | reporter.nih.gov |
| Causes and consequences of Blm-dependent DNA replication challenges | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $675,000 | September 1, 2022 | August 31, 2027 | STOFFREGEN, ERIC PAUL | reporter.nih.gov |
| Preparing for a Clinical Trial in Kabuki Syndrome- Characterization of Cognitive and Neuroanatomical Features and Pilot Treatment Trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $673,942 | July 20, 2020 | June 30, 2025 | HARRIS, JACQUELINE | reporter.nih.gov |
| Modeling CHARGE Syndrome with Human Inner Ear Organoids | NIH | National Institute on Deafness and Other Communication Disorders | 2025 | $670,318 | December 1, 2024 | November 30, 2029 | HASHINO, ERI | reporter.nih.gov |
| Developing Innovative Cell and Gene Therapy Strategies to Treat Fanconi Anemia | NIH | National Heart, Lung, and Blood Institute | 2025 | $662,949 | September 15, 2025 | June 30, 2030 | CZECHOWICZ, AGNIESZKA | reporter.nih.gov |
| A generic and immunological investigation of JAK-STAT in the pathogenesis of Celiac | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $661,824 | September 1, 2021 | April 30, 2026 | KONG, XIAO-FEI | reporter.nih.gov |
| Chronic STAT3 signaling in STAT3 GOF causes CD8 T cell dysfunction via CD39 upregulation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $658,426 | December 20, 2024 | November 30, 2029 | HENRICKSON, SARAH E | reporter.nih.gov |
| Donor Red Blood Cell Survival in Recipients with Sickle Cell Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $646,383 | September 15, 2025 | June 30, 2030 | YEE, MARIANNE ELAINE MCPHERSON | reporter.nih.gov |
| Ribosomes and growth regulation | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $628,000 | September 8, 2016 | August 31, 2027 | BAKER, NICHOLAS E | reporter.nih.gov |
| Uncovering Novel Regulatory Pathways and Functions of the Telomerase RNA Component in the Hematopoietic System | NIH | National Heart, Lung, and Blood Institute | 2025 | $623,874 | December 15, 2024 | November 30, 2025 | BATISTA, LUIS FRANCISCO ZIRNBERGER | reporter.nih.gov |
| Leveraging human iPSC technology to understand the role of neuroinflammation in 22q11.2 deletion syndrome | NIH | National Institute of Mental Health | 2025 | $610,784 | April 4, 2025 | January 31, 2030 | WEN, ZHEXING | reporter.nih.gov |
| Hematopoietic consequences of gain-of-function SAMD9 and SAMD9L mutations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $594,864 | November 1, 2020 | January 31, 2025 | SCHWARTZ, JASON ROSS | reporter.nih.gov |
| A C. Elegans Model of Fanconi Anemia Neurological Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $544,854 | June 1, 2025 | May 31, 2028 | HOWLETT, NIALL GEORGE | reporter.nih.gov |
| Glutathione reductase (Gsr) regulates cell metabolism and signaling during neutrophil-pathogen interactions | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $527,960 | August 18, 2025 | July 31, 2030 | LIU, YUSEN | reporter.nih.gov |
| Mechanism of inflammation in deficiency of adenosine deaminase 2 | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $522,524 | July 25, 2025 | June 30, 2030 | LEE, PUI YUEN | reporter.nih.gov |
| Multilevel factors influencing racial, ethnic, and socioeconomic disparities in hidradenitis suppurativa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $501,876 | September 15, 2023 | August 31, 2028 | CHANG, AILEEN YENTING | reporter.nih.gov |
| Targeting the immunoproteasome as a novel therapeutic strategy for hemophagocytic lymphohistiocytosis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $500,500 | July 5, 2023 | June 30, 2026 | NICHOLS, KIM ERIKA | reporter.nih.gov |
| miRNA buffering mechanisms and phenotypic variability in genetic syndromes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $500,500 | July 17, 2024 | June 30, 2026 | ZOHN, IRENE E | reporter.nih.gov |
| Inborn Errors of Immunity Leading to Autoinflammatory Syndromes | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $498,911 | April 20, 2024 | June 30, 2025 | BOGUNOVIC, DUSAN | reporter.nih.gov |
| Genetic Variants of Immune Dysregulation and Thrombotic Microangiopathy in Severe Pediatric Sepsis Induced Organ Dysfunction | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $489,244 | June 1, 2023 | May 31, 2027 | KERNAN, KATHRYN MARY | reporter.nih.gov |
| Antigen specificity of plasma cells in Hidradenitis suppurativa skin lesions | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $482,076 | July 17, 2024 | May 31, 2027 | JACOB, JOSHY | reporter.nih.gov |
| Mitochondrial mechanisms underlying neural stem and progenitor cell proliferation deficits in 22q11.2 deletion syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $462,510 | March 1, 2024 | February 28, 2029 | CAMPBELL, PHILIP | reporter.nih.gov |
| Validating interferon score and phospho-STING level as disease biomarkers of COPA syndrome | NIH | National Center for Advancing Translational Sciences | 2025 | $462,188 | July 17, 2025 | June 30, 2027 | SHUM, ANTHONY | reporter.nih.gov |
| Investigating abnormalities in top-down cortical processing and behavior in a model of the 22q11.2 deletion | NIH | National Institute of Mental Health | 2023 to 2024 | $462,000 | May 1, 2023 | April 30, 2025 | BATISTA-BRITO, RENATA | reporter.nih.gov |
| Radioresistant Innate Immunity in SAVI Tissue-Specific Autoinflammation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $460,625 | August 4, 2023 | July 31, 2025 | MARSHAK-ROTHSTEIN, ANN | reporter.nih.gov |
| Vaccine-induced SARS-CoV-2-specific T cell responses in patients with X-linked Agammaglobulinemia | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $445,633 | January 9, 2023 | December 31, 2025 | DE PARIS, KRISTINA | reporter.nih.gov |
| Novel mitochondria-targeting peptides (MTPs) as therapeutic intervention in Barth syndrome | NIH | National Heart, Lung, and Blood Institute | 2025 | $445,500 | January 15, 2025 | December 31, 2027 | SANDLERS, YANA I | reporter.nih.gov |
| Mechanisms of Impaired Granulopoiesis Due to CLPB Mutations | NIH | National Heart, Lung, and Blood Institute | 2025 | $445,000 | July 1, 2025 | June 30, 2028 | WARREN, JULIA THERESE | reporter.nih.gov |
| Mechanism of radial chromosome formation in human premature aging syndrome cells | NIH | National Institute on Aging | 2023 to 2024 | $444,124 | December 1, 2022 | November 30, 2024 | HENDRICKSON, ERIC A | reporter.nih.gov |
| Utilization of JAK inhibitor therapy in a transplant model of STAT1 GOF disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $441,375 | August 22, 2025 | July 31, 2027 | FORBES, LISA | reporter.nih.gov |
| FOXN1 variant regulation of T cell production | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $436,466 | July 2, 2025 | June 30, 2027 | VAN OERS, NICOLAI STANISLAS CYRILLE | reporter.nih.gov |
| FANCC mutation correction using homology-independent targeted integration for gene therapy of Fanconi Anemia group C | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $435,875 | July 15, 2023 | June 30, 2025 | TRAN, NGOC TUNG | reporter.nih.gov |
| Investigation of a Novel Inborn Error of Immunity with B Cell Deficiency | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $421,794 | December 12, 2023 | October 31, 2025 | COOPER, MEGAN ANNE | reporter.nih.gov |
| Genetic Variation and Inflammation-Dependent Hematopoietic Regulatory Networks | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $421,794 | January 1, 2024 | November 30, 2025 | BRESNICK, EMERY H. | reporter.nih.gov |
| In vivo and ex vivo gene editing for Artemis-deficient SCID | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $420,771 | July 7, 2025 | June 30, 2027 | MCIVOR, R. SCOTT | reporter.nih.gov |
| New insight into innate immune regulation through mechanistic studies of a novel oligoadenylate synthetase-like (OASL) gain-of-function variant | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $419,075 | June 1, 2024 | April 30, 2027 | CONN, GRAEME L | reporter.nih.gov |
| Molecular mechanisms of ribosome biogenesis by force-producing enzymes | NIH | National Institute of General Medical Sciences | 2025 | $392,500 | January 1, 2025 | December 31, 2029 | MICKOLAJCZYK, KEITH JOSEPH | reporter.nih.gov |
| Mechanisms of Impaired Granulopoiesis Due to CLPB Mutations | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $390,017 | July 1, 2021 | June 30, 2025 | WARREN, JULIA THERESE | reporter.nih.gov |
| Rewiring of RNA Polymerase II in a Novel Taspase1- Mediated Marrow Failure. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $390,000 | September 15, 2025 | June 30, 2030 | FORESTER, CRAIG M. | reporter.nih.gov |
| Mechanisms Contributing to T Cell Immune Dysregulation in STAT3 Gain-of-Function | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $389,412 | August 6, 2024 | July 31, 2029 | SCHMITT, ERICA G | reporter.nih.gov |
| Crosstalk of Immune Dysregulation and Impaired Wound Healing in inherited STAT4-mediated Autoinflammatory Disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $385,575 | February 1, 2025 | January 31, 2030 | BRODERICK, LORI | reporter.nih.gov |
| Protection of hematopoietic stem progenitor cells from endogenous DNA damage | NIH | National Heart, Lung, and Blood Institute | 2025 | $380,383 | April 21, 2025 | March 31, 2028 | JUNG, MOONJUNG | reporter.nih.gov |
| Bespoke Micellar Nanoparticles (MNPs) for In Vivo Delivery of Digital Base Editor Treatments for Primary Immunodeficiency Disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $380,000 | September 11, 2025 | August 31, 2026 | REINEKE, THERESA M | reporter.nih.gov |
| Impact of novel, non-classical type I interferon in HS pathophysiology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $366,053 | August 1, 2025 | June 30, 2027 | NELSON, AMANDA MARIE | reporter.nih.gov |
| Active non-viral nuclear delivery of DNA templates independent of mitosis | NIH | National Institute of General Medical Sciences | 2025 | $349,952 | September 1, 2025 | August 31, 2026 | ENGELHARDT, FLORIS ALASKA SILVIA | reporter.nih.gov |
| BMT Core - Pediatric Transplantation and Cellular Therapy Consortium (PTCTC): Providing Clinical Trial Access For Children With Life Threatening Diseases | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $349,037 | August 15, 2024 | June 30, 2031 | STEFANSKI, HEATHER E | reporter.nih.gov |
| Role of GM-CSF and impaired lipid metabolism in the pathogenesis of PAP | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $341,064 | September 18, 2024 | July 31, 2029 | LEE, ELINOR | reporter.nih.gov |
| Targeting cutaneous nociceptors to reduce Type-17 inflammation in hidradenitis suppurativa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $336,916 | May 1, 2024 | April 30, 2028 | WHITLEY, SARAH KERN | reporter.nih.gov |
| Insights from somatic genomics lead to novel therapeutic targets in inherited bone marrow failure syndromes: Shwachman-Diamond Syndrome as a model | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $336,722 | July 1, 2021 | March 31, 2026 | KENNEDY, ALYSSA | reporter.nih.gov |
| Anti-CD38 isatuximab Immunotherapy in Hidradenitis Suppurativa: a randomized, double-blinded, placebo-controlled, seamless phase 2a/2b trial | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $333,625 | August 1, 2025 | August 31, 2026 | MI, QING-SHENG | reporter.nih.gov |
| Using Bioinformatics Methodologies to Explore the Role of Short Interspersed Elements in the Pathogenesis of Idiopathic Inflammatory Myopathies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $329,616 | April 1, 2024 | March 31, 2029 | NAJJAR, RAYAN | reporter.nih.gov |
| G6PD Deficiency and Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2025 | $323,000 | March 4, 2025 | December 31, 2027 | MCNAMARA, COLEEN A | reporter.nih.gov |
| Gene Regulatory Mechanisms of Mll4 in Tooth Enamel Development | NIH | National Institute of Dental & Craniofacial Research | 2025 | $320,200 | July 15, 2025 | July 14, 2027 | LEE, JUNG-MI | reporter.nih.gov |
| Testing MALT1 inhibitors as a treatment for the rare pediatric inborn error of immunity CARD11 gain of function | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $313,176 | September 22, 2025 | February 28, 2027 | HOU, ANDREW | reporter.nih.gov |
| Evaluating a Novel Enzymatic Modality for the Treatment of Fanconi Anemia | NIH | National Heart, Lung, and Blood Institute | 2024 | $306,870 | August 20, 2024 | July 31, 2026 | CAO, MINGJU | reporter.nih.gov |
| Preclinical Development of LCTG-001, a Human Secretory IgA Replacement Therapy for CVID Patients | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $304,629 | January 24, 2025 | December 31, 2025 | MANE, VIRAJ PRAMOD | reporter.nih.gov |
| Development of sIgA from human milk as a therapeutic for Inflammatory bowel disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $303,427 | September 1, 2025 | August 31, 2026 | MANE, VIRAJ PRAMOD | reporter.nih.gov |
| In vivo targeted delivery of nucleic acids to hematopoietic stem cells for treating primary immunodeficiencies | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $300,000 | August 19, 2025 | July 31, 2027 | CHUNG, ALLEN | reporter.nih.gov |
| Safety of AAV-mediated C1 Esterase Inhibitor Gene Therapy for Hereditary Angioedema | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $275,737 | March 15, 2024 | November 30, 2025 | CRYSTAL, RONALD G | reporter.nih.gov |
| Mitochondrial influences on blood brain barrier function and neuropsychiatric illness | NIH | National Institute of Mental Health | 2024 | $257,399 | November 20, 2023 | March 31, 2024 | ALVAREZ, JORGE IVAN | reporter.nih.gov |
| A novel circuit underlying amotivation in a mouse model of 22q11DS | NIH | National Institute of Mental Health | 2025 | $249,000 | December 12, 2022 | May 31, 2028 | PATTON, MARY H. | reporter.nih.gov |
| A Proactive Missense Variant Atlas for the Autoimmune Regulator | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $238,500 | February 13, 2023 | January 31, 2025 | ROTH, FREDERICK P | reporter.nih.gov |
| Non-genotoxic HSCT for ATM | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $234,750 | September 1, 2024 | August 31, 2026 | CHANDRAKASAN, SHANMUGANATHAN | reporter.nih.gov |
| Modulation of neutrophil-endothelial interactions by ADAM10 | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $226,253 | January 23, 2025 | December 31, 2026 | BUBECK WARDENBURG, JULIANE | reporter.nih.gov |
| Autologous Non-viral CRISPR/Cas Homology-directed Repair for Artemis-deficient Severe Combined Immunodeficiency | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $200,016 | May 8, 2025 | April 30, 2030 | KAN, MATTHEW J | reporter.nih.gov |
| The role of GATA2 in myeloid malignancies and MonoMAC syndrome | NIH | National Cancer Institute | 2025 | $194,688 | January 1, 2025 | December 31, 2027 | KATERNDAHL, CASEY DUNCAN SAUL | reporter.nih.gov |
| Hematopoietic stem cell defects in Diamond-Blackfan Anemia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $179,880 | April 1, 2024 | March 31, 2026 | BHOOPALAN, SENTHIL VELAN | reporter.nih.gov |
| A novel circuit underlying amotivation in a mouse model of 22q11DS | NIH | National Institute of Mental Health | 2023 to 2024 | $176,748 | December 12, 2022 | November 30, 2024 | PATTON, MARY H. | reporter.nih.gov |
| Use of NLP to Extract Risk Indicators for Immunologic Disease from the Text of EHRs (UNIITE) | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $169,779 | February 18, 2022 | January 31, 2026 | RIDER, NICHOLAS L | reporter.nih.gov |
| Control of multilineage hematopoiesis by 5' cap-proximal modification | NIH | National Heart, Lung, and Blood Institute | 2025 | $164,160 | August 1, 2025 | May 31, 2030 | LEVINE, ANDREW | reporter.nih.gov |
| A somatic hypermutation defective UNG mutant in antibody deficiency through destabilization of RPA interaction. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $162,000 | June 1, 2024 | April 30, 2027 | MCBRIDE, KEVIN MICHAEL | reporter.nih.gov |
| Genome-wide dysregulation of R-loops in Ataxia Telangiectasia neurological pathogenesis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $141,408 | March 13, 2023 | January 12, 2026 | WESTOVER, KATHERINE R. | reporter.nih.gov |
| Investigating the role of telomere failure on intestinal stem cell niche function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $134,028 | August 1, 2023 | July 31, 2026 | KIM, MELISSA | reporter.nih.gov |
| Non-canonical roles for ATM kinase in regulating mitochondrial function and redox homeostasis | NIH | National Cancer Institute | 2022 to 2024 | $126,223 | June 1, 2022 | May 31, 2025 | BURRELL, PAIGE ELIZABETH | reporter.nih.gov |
| An Engineered Hydrogel Platform to Improve Neural Organoid Reproducibility for a Multi-Organoid Disease Model of 22q11.2 Deletion Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $113,017 | June 16, 2023 | December 15, 2025 | HUANG, MICHELLE S | reporter.nih.gov |
| Investigation of Chromatin Modifiers to Elucidate the Phenotypic Variability of Congenital Heart Disease in Patients with 22q11.2 Deletion Syndrome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $108,512 | January 16, 2024 | July 15, 2027 | MILLER, DANIELLA | reporter.nih.gov |
| Mapping functional brain connectivity, neurodevelopment, and imaging-genetic associations in individuals with genetic and clinical risk factors for neuropsychiatric illness | NIH | National Institute of Mental Health | 2023 to 2024 | $93,721 | September 1, 2023 | August 31, 2025 | SCHLEIFER, CHARLES | reporter.nih.gov |
| The Role of Monoallelic Expression in Incomplete Penetrance of Primary Immunodeficiencies | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $85,521 | June 22, 2023 | December 22, 2024 | STEWART, O'JAY | reporter.nih.gov |
| Identification of biologically relevant subtypes of hidradenitis suppurativa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $83,905 | June 1, 2024 | May 31, 2026 | PETUKHOVA, LYNN | reporter.nih.gov |
| Enhancer Hijacking of the IgH Locus as a Novel Genetic Mechanism of Inborn Errors of Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $68,733 | August 1, 2024 | June 30, 2026 | TOBIN, JOSHUA | reporter.nih.gov |
| A novel genetic mutation reveals the molecular and cellular mechanisms of severe recurrent skin inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $67,220 | April 1, 2023 | March 31, 2025 | GIL, HWI (DEBORAH) M | reporter.nih.gov |
| Annual Primary Immune Deficiency Treatment Consortium (PIDTC) Workshop and Education Day | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $60,000 | March 8, 2011 | February 28, 2026 | PUCK, JENNIFER M. | reporter.nih.gov |
| Dysregulation of Gamma Secretase in Common Acquired Hidradenitis Suppurativa | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $54,538 | May 15, 2025 | May 14, 2028 | MINSKY, HANA BLEICHER | reporter.nih.gov |
| Understanding how defects in the maternal epigenetic reprogramming function of LSD1/KDM1A contribute to inherited phenotypes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $49,538 | April 1, 2025 | March 31, 2028 | REEVES, MONICA | reporter.nih.gov |
| Determining the function of Tbx1 in the pharyngeal endoderm for aortic arch development | NIH | National Heart, Lung, and Blood Institute | 2025 | $49,538 | June 16, 2025 | June 15, 2028 | JACKSON, KEVYN E | reporter.nih.gov |
| Investigating the roles of the H3K4 methyltransferases KMT2C and KMT2D in chondrocyte differentiation and endochondral ossification | NIH | National Institute of Dental & Craniofacial Research | 2024 | $43,374 | August 1, 2024 | October 31, 2026 | QUICKSTAD, GABRIELLE ALAIR | reporter.nih.gov |
| Influence of Maternal IgA on Neonatal iNKT Cell Development and Gluten Sensitive Enteropathy. | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $41,778 | May 15, 2025 | May 14, 2028 | BALL, RYAN ALBERT WILLIAM | reporter.nih.gov |
| 2024 Scientific and Medical Conference on Barth Syndrome: Benchtop to Treatments | NIH | National Heart, Lung, and Blood Institute | 2024 | $40,000 | August 1, 2024 | July 31, 2025 | GREENBERG, MIRIAM L | reporter.nih.gov |
| Linking GATA2 deficiency to innate immune signaling | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $36,306 | December 1, 2024 | April 28, 2025 | TRAN, VU LE-HUY | reporter.nih.gov |
| In vivo hematopoietic stem cell gene therapy in a novel genetically humanized murine model of SCID-A | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $36,093 | September 22, 2025 | October 21, 2027 | EATON, ELLA JOY | reporter.nih.gov |
| Single-Cell Analysis of Somatic Mutation Rates, Mechanisms, and Impacts in Human Ataxia Telangiectasia Cerebellum | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $34,454 | May 1, 2025 | October 31, 2028 | CLASS, BRADLEY | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 170 | $92,393,110 | 0 | $0 |
| 2024 | 167 | $85,631,666 | 0 | $0 |
| 2023 | 107 | $58,631,210 | 0 | $0 |
| 2022 | 76 | $45,825,458 | 0 | $0 |
| 2021 | 51 | $26,547,654 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 5 awards here | |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | PA-24-182 | NIH | May 8, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 81 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 81 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 81 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 81 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 81 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 81 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 81 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 81 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 81 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 81 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 81 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 81 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 81 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 81 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 81 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 81 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 81 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 81 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.